http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31603069

Outgoing Links

Predicate Object
contentType Evaluation Study|Journal Article|Research Support, Non-U.S. Gov't
endingPage 563
issn 1532-1827
0007-0920
issueIdentifier 4
pageRange 559-563
publicationName British Journal of Cancer
startingPage 559
bibliographicCitation Yun J, Kim KH, Kang ES, Gwak G, Choi MS, Lee JE, Nam SJ, Yang J, Park YH, Ahn JS, Im Y. Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy. British Journal of Cancer. 2011 Feb 01;104(4):559–63. doi: 10.1038/bjc.2011.4.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e46030ad3f1a414f4e4c23cc6bb92142
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ceda76f7c7583b0a76f6f230f3c37f0c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a63f9f1c4ca9aa08733581669000dca0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8cb4e8a82e758ee973cd8e627888501d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0db1ee60439db15135fb07e01e752877
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_261b0d722c4546e08c048b1ab26ea09d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_de18188a12fe191addd25c28aa06888e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05258dd71f04f2d071ddaa0315b93bbd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d05febc56489ae874c7f3c208e4a9ab
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6866eb4897af5d7b53ab21829640d3c1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f8632bd0e3da58fe5db25a745a40227
date 2011-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC3049600
https://pubmed.ncbi.nlm.nih.gov/21285992
https://doi.org/10.1038/bjc.2011.4
isPartOf https://portal.issn.org/resource/ISSN/0007-0920
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
https://portal.issn.org/resource/ISSN/1532-1827
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy
discusses http://id.nlm.nih.gov/mesh/M0028312
http://id.nlm.nih.gov/mesh/M0001348
http://id.nlm.nih.gov/mesh/M0028682
http://id.nlm.nih.gov/mesh/M0001518
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7987
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7989
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30323
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135789409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127952853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129233080
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129046631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136262261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135808554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128713593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128397534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129613204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128324017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127638306

Total number of triples: 59.